Lumea and Paige partner to integrate AI-powered workflows, enhancing diagnostic efficiency and accessibility in cancer care. LEHI, UT, UNITED STATES, June 3, 2025 /EINPresswire.com/ — Lumea, the U.S. leader in…
Read More
Lumea and AIxMed team up to bring AI-driven urine cytology to Lumea's platform, targeting improved bladder cancer diagnostics. LEHI, UT, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Lumea, a leading...
Read More
Lehi, Utah — May 13, 2025 — Lumea, a leader in digital pathology and workflow innovation, is pleased to announce the upcoming transition of the Chief Executive Officer role, which...
Read More
A Summary of Staci Kearney’s presentation at the Digital Diagnostic Summit 2024 The Current State of the FDA’s Final Rule On May 6, 2024, the FDA issued its final rule…
LEHI, UT, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Lumea, a leader in digital pathology solutions. AIRA Matrix Private Limited, an innovative technology company for AI-based diagnostic, prognostic, and predictive...
Read More
Lumea’s Digital Diagnostic Suite™ (Viewer+™) Receives FDA 510(k) Clearance* for Clinical Diagnosis LEHI, UTAH, UNITED STATES, March 18, 2025 /EINPresswire.com/ – Lumea, a leader in digital pathology solutions, is proud…
